Synthesis and Kinetic evaluation of an azido analogue of methylerythritol phosphate: a Novel Inhibitor of E. coli YgbP/IspD

As multidrug resistant pathogenic microorganisms are a serious health menace, it is crucial to continuously develop novel medicines in order to overcome the emerging resistance. The methylerythritol phosphate pathway (MEP) is an ideal target for antimicrobial development as it is absent in humans bu...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports Vol. 8; no. 1; pp. 17892 - 10
Main Authors: Baatarkhuu, Zoljargal, Chaignon, Philippe, Borel, Franck, Ferrer, Jean-Luc, Wagner, Alain, Seemann, Myriam
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 17-12-2018
Nature Publishing Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As multidrug resistant pathogenic microorganisms are a serious health menace, it is crucial to continuously develop novel medicines in order to overcome the emerging resistance. The methylerythritol phosphate pathway (MEP) is an ideal target for antimicrobial development as it is absent in humans but present in most bacteria and in the parasite Plasmodium falciparum . Here, we report the synthesis and the steady-state kinetics of a novel potent inhibitor (MEPN 3 ) of Escherichia coli YgbP/IspD, the third enzyme of the MEP pathway. MEPN 3 inhibits E . coli YgbP/IspD in mixed type mode regarding both substrates. Interestingly, MEPN 3 shows the highest inhibitory activity when compared to known inhibitors of E . coli YgbP/IspD. The mechanism of this enzyme was also studied by steady-state kinetic analysis and it was found that the substrates add to the enzyme in sequential manner.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-018-35586-y